BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema
- First Posted Date
- 2007-06-20
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Bayer
- Target Recruit Count
- 40
- Registration Number
- NCT00488241
- Locations
- 🇩🇪
Intendis GmbH, Berlin, Germany
Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens
Phase 4
Completed
- Conditions
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2009-06-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 500
- Registration Number
- NCT00481689
A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-05-25
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 397
- Registration Number
- NCT00478881
Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-05-15
- Last Posted Date
- 2014-10-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1404
- Registration Number
- NCT00473460
Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-05-10
- Last Posted Date
- 2013-01-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 60
- Registration Number
- NCT00471991
Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men
- First Posted Date
- 2007-05-08
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Bayer
- Target Recruit Count
- 2471
- Registration Number
- NCT00470873
Assessment of Compliance With Antihypertensive Telmisartan Therapy
- First Posted Date
- 2007-05-08
- Last Posted Date
- 2012-11-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 3400
- Registration Number
- NCT00470886
The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension
- First Posted Date
- 2007-05-08
- Last Posted Date
- 2010-01-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 5448
- Registration Number
- NCT00471003
A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-05-03
- Last Posted Date
- 2015-07-22
- Lead Sponsor
- Bayer
- Target Recruit Count
- 140
- Registration Number
- NCT00468819
Efficacy and Safety Study for an Oral Contraceptive Containing Folate
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-05-02
- Last Posted Date
- 2014-04-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 385
- Registration Number
- NCT00468481
- Locations
- 🇺🇸
NorthWest Kinetics, Tacoma, Washington, United States
🇺🇸Lyndhurst Gynecologic Associates, Winston-Salem, North Carolina, United States
🇺🇸Orange County Clinical Trials, Anaheim, California, United States
© Copyright 2024. All Rights Reserved by MedPath